asco.org3d
Conflict of Interest (COI)
The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...
asco.org4d
Topical Mentoring Opportunities
Throughout the year, members can sign-up to participate in virtual meetings focused on specific training or career topics. Members can select from a list of mentors per meeting topic. At the end of ...
asco.org4d
The Conquer Cancer Patient Advocate Scholarship Program
The scholarship application period for the 2025 ASCO Annual Meeting will open on Monday, March 10 at 10:00 AM and close on Monday, March 17 at 5:00 PM (ET). Please read the eligibility and criteria ...
asco.org4d
Resilience Skills Training Program
The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...
asco.org4d
Staff Well-Being & Development
Recruiting and developing oncology practice staff takes care and strategy. ASCO can be a unique resource as you search for ideal candidates and work to bolster the expertise and efficiency of your ...
asco.org6d
Management of growing teratoma syndrome: Aachen University experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Surgical management of testicular cancer patients with complex postchemotherapy residual masses: Aachen University experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Long-term outcomes of radiotherapy for stage II testicular seminoma: The Mayo Clinic experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Efficacy and hematologic toxicity of carboplatin and talazoparib combination therapy in BRCA mutated patients.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
A phase I study of carboplatin and talazoparib in patients with and without DNA repair mutations.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Comprehensive molecular profiling of advanced gastric cancer (AGC) using NGS and immunohistochemistry (IHC).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...